|
ANXA5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.4021000178418E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57229995689789E-09 |
| Normal-vs-Stage2 |
5.236900E-04 |
| Normal-vs-Stage3 |
5.15959999947135E-07 |
| Normal-vs-Stage4 |
2.02059999843129E-08 |
| Stage1-vs-Stage2 |
5.380000E-01 |
| Stage1-vs-Stage3 |
5.370800E-01 |
| Stage1-vs-Stage4 |
1.001590E-01 |
| Stage2-vs-Stage3 |
3.778200E-01 |
| Stage2-vs-Stage4 |
9.793900E-02 |
| Stage3-vs-Stage4 |
4.109400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.13960002440439E-09 |
| Normal-vs-AfricanAmerican |
2.004800E-03 |
| Normal-vs-Asian |
6.346200E-02 |
| Caucasian-vs-AfricanAmerican |
2.186200E-02 |
| Caucasian-vs-Asian |
6.488400E-01 |
| AfricanAmerican-vs-Asian |
7.078200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.37269999600909E-08 |
| Normal-vs-Female |
4.87819995509398E-09 |
| Male-vs-Female |
5.903200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.524500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.61550000044031E-08 |
| Normal-vs-Age(61-80Yrs) |
3.65490004927693E-09 |
| Normal-vs-Age(81-100Yrs) |
3.482600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.162400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.500600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.174800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.591200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.410800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.666600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.430800E-04 |
| Normal-vs-Grade 2 |
2.2149000411531E-09 |
| Normal-vs-Grade 3 |
4.06840000022335E-07 |
| Normal-vs-Grade 4 |
3.01519999967859E-07 |
| Grade 1-vs-Grade 2 |
7.951200E-01 |
| Grade 1-vs-Grade 3 |
2.169000E-01 |
| Grade 1-vs-Grade 4 |
9.542400E-01 |
| Grade 2-vs-Grade 3 |
7.756300E-02 |
| Grade 2-vs-Grade 4 |
6.912400E-01 |
| Grade 3-vs-Grade 4 |
9.716400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.47559964247534E-10 |
| Normal-vs-ccB subtype |
1.05539998962456E-09 |
| ccA subtype-vs-ccB subtype |
7.826200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.95590038293881E-10 |
| Normal-vs-N1 |
7.140400E-03 |
| N0-vs-N1 |
2.415800E-01 |
|
|
